UNiTY

A randomised controlled trial evaluating the clinical and cost effectiveness of Intra Utertine Insemination versus In-Vitro Fertilisation for UNexplained infertiliTY.

This page is for fertility professionals. For more information for patients and couples please see Spermeggembryo | Future Generations

UNiTY is now open for recruitment, please get in contact with the UNiTY Trial Study Office if you have any enquiries. Many thanks to all sites and participants for your continued support. 

Sponsored by University of Birmingham 

UNITY logo

 

Aim

To evaluate the clinical and cost effectiveness of up to three cycles of Intra Uterine Insemination (IUI), compared to one cycle of In-Vitro Fertilisation (IVF) in couples with unexplained infertility. 

Trial Design

Parallel, open, multicentre, non-inferiority, randomised controlled trial with integrated economic, healthcare science and bioethics evaluations, including an internal pilot with embedded Qualitative Process Evaluation. 

Participant population and sample size

Couples with a diagnosis of unexplained infertility. The trial will recruit 942 couples in total, 471 per group at a 1:1 randomisation ratio. 

Setting

Human Fertilisation and Embryology Authority (HFEA) licenced fertility treatment centres in the UK. 

Arms

Intervention: Three cycles of letrozole stimulated Intra Uterine Insemination (IUI).

Control: One cycle of In-Vitro Fertilisation (IVF) with standard ovarian stimulation and first fresh or frozen embryo transfer. 

Outcomes

The primary outcome is live birth ≥34 weeks gestation conceived within 270 days (approximately 9 months) of randomisation, assessed at 19 months post-randomisation.